Observational Safety Study of Rituximab in Patients Diagnosed With Rheumatoid Arthritis (RA) Who Did Not Respond Adequately to TNF-alpha Blocker
Clinical trial NCT02322801 · COMPLETED
Trial details
- NCT number
- NCT02322801
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2009-03-01
- Primary completion
- 2011-11-01
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.